Literature DB >> 7917924

Prognosis based on primary breast carcinoma instead of pathological nodal status.

S Ménard1, R Bufalino, F Rilke, N Cascinelli, U Veronesi, M I Colnaghi.   

Abstract

In breast cancer patients, prognostic information required to plan post-surgical therapy is obtained mainly through axillary dissection. This study was designed to establish a new prognostic score based solely on parameters of the primary tumour as an alternative to axillary surgery in assessing prognosis. Eight different prognostic factors, including menopausal status, tumour size, grading, lymphatic invasion, desmoplasia, necrosis, c-erbB-2 and laminin receptor expression, were evaluated retrospectively on a large series of primary breast carcinoma patients. From multivariate analysis, four independent parameters were selected and examined, alone and in combination, for their prognostic potential. These parameters were used to generate a prognostic score that was analysed retrospectively in 467 N0-N1a patients to determine its predictive value for survival. The score, which includes variables such as tumour size, grading, laminin receptor and c-erbB-2 overexpression, was established based on the number of negative prognostic factors: score 1 refers to cases in which all four parameters reflect a good prognosis, scores 2 and 3 refer to tumours in which, respectively, one or two of the four parameters reflect a poor prognosis, whereas score 4 refers to tumours with three or four poor prognosis factors. Analysis of the overall survival of the four score groups shows that patients with score 1 tumours (22% of the total) had the best prognosis with a 15 year survival of 82%, patients with score 2 and 3 had an intermediate prognosis, whereas score 4 patients had the poorest prognosis with a 15 year survival of only 38%. Moreover, survival in the N+ score 1 cases was found to be longer than that in the total N- patients. Our data suggest that the primary tumour score provides more reliable prognostic information than pathological nodal status, and that axillary dissection can be avoided in a large number of patients.

Entities:  

Mesh:

Year:  1994        PMID: 7917924      PMCID: PMC2033423          DOI: 10.1038/bjc.1994.379

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression.

Authors:  S Martignone; R Pellegrini; E Villa; N N Tandon; A Mastroianni; E Tagliabue; S Ménard; M I Colnaghi
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

2.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 3.  p53 mutations, another breast cancer prognostic factor.

Authors:  R Callahan
Journal:  J Natl Cancer Inst       Date:  1992-06-03       Impact factor: 13.506

4.  Manchester regional breast study. Preliminary results.

Authors:  J P Lythgoe
Journal:  Lancet       Date:  1978-04-08       Impact factor: 79.321

5.  C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer.

Authors:  M Noguchi; N Koyasaki; N Ohta; H Kitagawa; M Earashi; M Thomas; I Miyazaki; Y Mizukami
Journal:  Cancer       Date:  1992-06-15       Impact factor: 6.860

6.  Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas.

Authors:  S Martignone; S Ménard; R Bufalino; N Cascinelli; R Pellegrini; E Tagliabue; S Andreola; F Rilke; M I Colnaghi
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

7.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

8.  Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses.

Authors:  R Lupu; R Colomer; B Kannan; M E Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

9.  Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up.

Authors:  S Bosari; A K Lee; G Viale; G J Heatley; G Coggi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

10.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

View more
  8 in total

1.  Flow Cytometric Assay of c-erbB-2 Protein in Fine Needle Aspirates of Fresh and Frozen Human Breast Cancer Tissues.

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

2.  A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up.

Authors:  Gabriele Martelli; Patrizia Boracchi; Michaela De Palo; Silvana Pilotti; Saro Oriana; Roberto Zucali; Maria Grazia Daidone; Giuseppe De Palo
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

3.  Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis.

Authors:  M Greco; R Agresti; N Cascinelli; P Casalini; R Giovanazzi; A Maucione; G Tomasic; C Ferraris; M Ammatuna; S Pilotti; S Menard
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

4.  Questioning the role of axillary node dissection in sentinel node positive early stage breast cancer in the South Eastern Cancer Centre.

Authors:  O O Mohamed; P M Neary; C Fiuza-Castineira; G T O'Donoghue
Journal:  Ir J Med Sci       Date:  2014-03-02       Impact factor: 1.568

Review 5.  FDG-PET for axillary lymph node staging in primary breast cancer.

Authors:  Flavio Crippa; Alberto Gerali; Alessandra Alessi; Roberto Agresti; Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-05       Impact factor: 9.236

6.  Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis.

Authors:  Guislaine Barrière; Alain Riouallon; Joël Renaudie; Michel Tartary; Michel Rigaud
Journal:  BMC Cancer       Date:  2012-03-23       Impact factor: 4.430

7.  A predictive index of axillary nodal involvement in operable breast cancer.

Authors:  M De Laurentiis; C Gallo; S De Placido; F Perrone; G Pettinato; G Petrella; C Carlomagno; L Panico; P Delrio; A R Bianco
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

8.  The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer.

Authors:  T Kato; S Kameoka; T Kimura; T Nishikawa; M Kobayashi
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.